ERBB2 and goblet cell carcinoma: Table 1 summarises the percentage of SP cells and surface HER2 expression in a panel of BC cells, including recently established primary BC cell lines freshly derived from patient specimens designated as GCC-BC1, -BC2, -BC3, and -BC4 (Supplementary Table S1).